Oct 27 2024 17 mins 3
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a new, more precise name for nonalcoholic fatty liver disease. Fernando Bril, M.D., an endocrinologist, explains how this name precisely describes the way in which fatty acids build up in the liver of patients who have insulin resistance. Learn more about the close relationship of MASLD, type 2 diabetes, and obesity. Dr. Bril reviews current screening recommendations, effective interventions, and the first approved drug for the condition.
